218 related articles for article (PubMed ID: 25937244)
1. Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study.
Terenzi R; Santoboni G; Bartoloni E; Alunno A; Luccioli F; Gerli R
Clin Exp Rheumatol; 2015; 33(3):445. PubMed ID: 25937244
[No Abstract] [Full Text] [Related]
2. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
[No Abstract] [Full Text] [Related]
3. Clinical and ultrasound evaluation of the response to tocilizumab treatment in patients with rheumatoid arthritis: a case series.
Epis O; Filippucci E; Delle Sedie A; De Matthaeis A; Bruschi E
Rheumatol Int; 2014 May; 34(5):737-42. PubMed ID: 23354163
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre.
Addimanda O; Possemato N; Macchioni P; Salvarani C
Clin Exp Rheumatol; 2014; 32(4):460-4. PubMed ID: 24960220
[TBL] [Abstract][Full Text] [Related]
5. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
[TBL] [Abstract][Full Text] [Related]
6. Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results.
Benucci M; Manfredi M; Saviola G; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2013; 31(2):322-3. PubMed ID: 23380047
[No Abstract] [Full Text] [Related]
7. Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab.
Fusama M; Nakahara H; Hamano Y; Nishide M; Kawamoto K; Hosokawa T; Nozato S; Higa S; Igarashi T; Takeuchi E; Kuroiwa T; Shimaoka Y; Yukioka M; Miura Y; Higashi K; Kuritani T; Maeda K
Mod Rheumatol; 2013 Mar; 23(2):276-83. PubMed ID: 22669600
[TBL] [Abstract][Full Text] [Related]
8. Proposing a method of regional assessment and a novel outcome measure in rheumatoid arthritis.
Nishiyama S; Aita T; Yoshinaga Y; Kishimoto H; Toda M; Yoshihara Y; Miyoshi S; Manki A; Miyawaki S
Rheumatol Int; 2012 Aug; 32(8):2569-71. PubMed ID: 21789609
[TBL] [Abstract][Full Text] [Related]
9. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritis.
Behrens F; Tony HP; Alten R; Kleinert S; Scharbatke EC; Köhm M; Gnann H; Tams J; Greger G; Burkhardt H
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1608-16. PubMed ID: 23609999
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of ultrasonographic assessment of disease activity in response to tumor necrosis factor-α inhibitor treatment in rheumatoid arthritis: a prospective cohort study.
Inanc N; Ozen G; Direskeneli H
Clin Exp Rheumatol; 2016; 34(1):156. PubMed ID: 26575409
[No Abstract] [Full Text] [Related]
12. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H
Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090
[TBL] [Abstract][Full Text] [Related]
13. Baseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.
Kawashiri S; Ueki Y; Migita K; Nakamura H; Aoyagi K; Kawakami A
Clin Exp Rheumatol; 2014; 32(3):445. PubMed ID: 24850342
[No Abstract] [Full Text] [Related]
14. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
Wakefield RJ; Freeston JE; Hensor EM; Bryer D; Quinn MA; Emery P
Arthritis Rheum; 2007 Dec; 57(8):1564-7. PubMed ID: 18050231
[No Abstract] [Full Text] [Related]
15. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
Epis O; Casu C; Belloli L; Schito E; Filippini D; Muscarà M; Bruschi E
Rheumatol Int; 2015 Sep; 35(9):1569-70. PubMed ID: 25773656
[No Abstract] [Full Text] [Related]
16. Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study.
Gossec L; Steinberg G; Rouanet S; Combe B
Clin Exp Rheumatol; 2015; 33(5):664-70. PubMed ID: 26344671
[TBL] [Abstract][Full Text] [Related]
17. RADAI-5 to monitor rheumatoid arthritis.
Leeb BF; Haindl PM; Brezinschek HP; Nothnagl T; Rintelen B
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-55-8. PubMed ID: 25365090
[TBL] [Abstract][Full Text] [Related]
18. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
Kotak S; Mardekian J; Horowicz-Mehler N; Shah A; Burgess A; Kim J; Gemmen E; Boyd H; Koenig A
Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH
Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis.
Kamishima T; Kato M; Atsumi T; Koike T; Onodera Y; Terae S
Clin Exp Rheumatol; 2013; 31(1):154. PubMed ID: 23190694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
